Professional
Added to YB: 2024-05-09
Pitch date: 2024-05-01
PFE [bullish]
Pfizer Inc.
+6.5%
current return
Author Info
No bio for this author
Company Info
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
Market Cap
$146.5B
Pitch Price
$24.27
Price Target
42.00 (+62%)
Dividend
6.67%
EV/EBITDA
7.56
P/E
14.98
EV/Sales
3.09
Sector
Pharmaceuticals
Category
value
Pfizer Inc.: Solid Results Supported by Steady Tracking Toward $4 Billion in Cost Cuts
$PFE - Wide-moat pharma giant undervalued as market underappreciates margin expansion potential from $4B in cost cuts by end of 2024. Q1 sales +11% (ex-COVID), rare disease drug Vyndaqel +66%. Risks: intensifying generics for Eliquis by 2026, Prevnar pressure from Merck's V116. $42 FVE on lower 2024 guide, but div secure. Cost cuts & new drugs to drive growth.
Read full article (8 min)